Skip to main navigation Skip to search Skip to main content

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting

Sarah Romanelli*, Gretchen D. Ball, Arianna J. Zhang, Christina Asare, Audrey Hao, Hassan Hamade, Grace M. Hren, Yvonne Nong, John S. Barbieri, Saakshi Khattri, Tarannum Jaleel, Winston W. Liu, Brian Kim, Michi Shinohara, Cecilia Larocca, Daniel Butler, Daniel Siegel, Nanette Silverberg, Silvia F. Barrio, Robin ChristensenAthena Ehlert, John Latella, Vibeke Strand, April W. Armstrong, Lourdes Perez-Chada, Joseph F. Merola Md, Alice B. Gottlieb

*Corresponding author for this work

Abstract

Background: International Dermatology Outcome Measures (IDEOM) is a nonprofit organization committed to advancing the development and accessibility of evidence-based, consensus-driven outcome measures in dermatology. This mission is supported by a diverse group of stakeholders who collaborate to improve the research and treatment of dermatologic disease. Summary: The 2024 IDEOM Annual Meeting was held on April 5-6, 2024. During the event, work groups in psoriatic disease, hidradenitis suppurativa, geriatric dermatology, connective tissue disease, vitiligo, itch, actinic keratosis, acne, and cutaneous T-cell lymphoma discussed research progress and conducted breakout sessions. This report summarizes each workgroup’s updates. Key Messages: This report outlines the key research advancements made by each IDEOM workgroup at the 2024 IDEOM Annual Meeting.

Original languageEnglish
JournalJournal of Drugs in Dermatology
Volume24
Issue number12
Pages (from-to)1215-1221
Number of pages7
ISSN1545-9616
DOIs
Publication statusPublished - Dec 2025

Fingerprint

Dive into the research topics of 'Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting'. Together they form a unique fingerprint.

Cite this